Evidence map›Paper›PMID 34854279›Full record

GuidelineHaematologica2022

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS.

Eline J M Bertrums, C Michel Zwaan, Daisuke Hasegawa, Valerie De Haas, Dirk N Reinhardt, Franco Locatelli, Barbara De Moerloose, Michael Dworzak, Arjan Buijs, Petr Smisek and 12 more

Open access · goldAbstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Too many white cells-TAM, JMML, or something else?Hematology. American Society of Hematology. Education Program · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 19 institutions in 13 countries.

Eline J M BertrumsPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC, Rotterdam, the Netherlands; Oncode Institute, Utrecht. e.j.m.bertrums@prinsesmaximacentrum.nl.
C Michel ZwaanPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC, Rotterdam.
Daisuke HasegawaDepartment of Pediatrics, St. Luke's international Hospital, Tokyo.
Valerie De HaasPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Dutch Childhood Oncology Group (DCOG), Utrecht.
Dirk N ReinhardtDepartment of Pediatric Oncology, University of Duisburg-Essen, Essen.
Franco LocatelliSapienza, University of Rome Department of Pediatric Hematology-Oncology, IRCCS Bambino Gesù Children's Hospital, Rome.
Barbara De MoerlooseDepartment of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent.
Michael DworzakChildren's Cancer Research Institute and St. Anna Kinderspital, Department of Pediatrics, Medical University of Vienna, Vienna.
Arjan BuijsDepartment of Genetics, University Medical Center, Utrecht.
Petr SmisekDepartment of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague.
Alexandra KolenovaDepartment of Pediatric Hematology and Oncology, Comenius University Children's Hospital, Bratislava.
Cornelis Jan PronkChildhood Cancer Center, Skåne University Hospital, Lund.
Jan-Henning KlusmannPediatric Hematology, Oncology and Hemostaseology, Hospital for Children and Adolescents, University Hospital of Frankfurt/Main, Goethe-University Frankfurt/Main, Frankfurt.
Ana CarbonéDepartment of Pediatric Onco-Hematology, University Hospital Miguel Servet, Zaragoza.
Alina FersterDepartment of Hemato-Oncology, Immunology and Transplantation, University Pediatric Hospital Reine Fabiola (ULB), Brussels.
Evangelia AntoniouDepartment of Pediatric Oncology, University of Duisburg-Essen, Essen.
Soheil MeshinchiFred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA.
Susana C RaimondiDepartment of Pathology, St. Jude Children's Hospital, Memphis, TN.
Charlotte M NiemeyerDivision of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg.
Henrik HasleDepartment of Pediatrics, Aarhus University Hospital, Aarhus.
Marry M Van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands University of Utrecht, Utrecht.
Bianca F GoemansPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Dutch Childhood Oncology Group (DCOG), Utrecht.
Princess Máxima Center · NLUniversity of Duisburg-Essen · DEAarhus University Hospital · DKBambino Gesù Children's Hospital · ITCharles University · CZChildren's Clinical University Hospital · LVErasmus University Rotterdam · NLFred Hutch Cancer Center · USGhent University Hospital · BEGoethe University Frankfurt · DEHospital Universitario Miguel Servet · ESOncode Institute · NLQueen Fabiola Children's University Hospital · BESkåne University Hospital · SESt Anna Children's Hospital · ATSt. Jude Children's Research Hospital · USSt. Luke's International Hospital · JPUniversity Medical Center Freiburg · DEUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesMyeloproliferative DisordersHumansInfant, Newborn

Identifiers

PMID34854279
PMCPMC8883540
OpenAlexW3217573580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.